Compare Marsh & McLennan Companies, Inc. (MRSH) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marsh & McLennan Companies, Inc. vs Health Care Select Sector SPDR Fund — how do they compare? Marsh & McLennan Companies, Inc. trades at $175.76 (market cap $84.31B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Marsh & McLennan Companies, Inc. is the larger of the two by market cap, and Marsh & McLennan Companies, Inc. pays a 2.24% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marsh & McLennan Companies, Inc. for 109 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| MRSH | XLV | |
|---|---|---|
Market Cap | $84.31B | $43.48B |
Volume | 3,948,947 | 11,121,431 |
Sector | Financials | — |
52-Week High | $207.02 | $175.68 |
52-Week Low | $157.32 | $141.95 |
Typical Hold Time | 109 Days | 100 Days |
Enterprise Value | $104.99B | — |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marsh (MRSH) trades at $176.67, up 1.73% today, with a bullish technical trend and strong support at $174. The company shows robust fundamentals, with revenue growing to $26.98B in 2025 and a net income margin of 14.24%. Recent acquisition of Accel Holdings (Business Wire, 2026-10-02) may enhance growth. Earnings have consistently beaten estimates in recent quarters, with Q3 2026 results pending.
Outlook is positive with a consensus price target of $202.71 (MarketBeat, 2026-09-30), offering ~15% upside. Risks include competitive pressures and market volatility. Analyst sentiment is mixed, with 32% buy ratings but 65% hold, suggesting cautious optimism amid solid execution.
XLV trades at $168.16, down 0.39% on the day, with technical indicators showing a bearish bias as the ETF tests key support levels. The healthcare ETF maintains a competitive 0.08% expense ratio and offers diversified exposure to 60 S&P 500 healthcare stocks. Recent options activity shows increased put volume, suggesting some investor caution despite the sector's defensive characteristics.
The healthcare sector's defensive nature and potential Fed rate hike resilience provide stability, though technical weakness and political volatility around midterm elections present near-term risks. XLV's low-cost structure and broad diversification make it an efficient vehicle for healthcare exposure, but sector-specific headwinds like drug trial failures warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
